Growth Factor Complex

Drug Profile

Growth Factor Complex

Alternative Names: GFC

Latest Information Update: 13 Nov 2000

Price : $50

At a glance

  • Originator Institute for Pharmaceutical Research
  • Class Growth factors
  • Mechanism of Action Intercellular signalling peptide and protein stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.


Highest Development Phases

  • No development reported Skin disorders

Most Recent Events

  • 13 Nov 2000 No-Development-Reported for Skin disorders in Switzerland (Topical)
  • 13 Nov 2000 No-Development-Reported for Skin disorders in Germany (Topical)
  • 31 Jul 1997 Phase-II clinical trials for Skin disorders in Germany (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top